Correction

Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif (vol 53, pg 1843, 2010)

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Volume 53, Issue 8, Pages 3422-3422

DOI: 10.1021/jm100354s

Click your name to claim this paper and add it to your profile.